Vertex Pharmaceuticals Incorporated
Treating cancer with ATR inhibitors
Last updated:
Abstract:
This invention relates to methods and compositions for treating pancreatic cancer. More specifically, this invention relates to treating pancreatic cancer with certain ATR inhibitors in combination with gemcitabine and/or radiation therapy. This invention also relates to methods and compositions for treating non-small cell lung cancer. More specifically, this invention relates to treating non-small cell lung cancer with an ATR inhibitor in combination with cisplatin or carboplatin, etoposide, and ionizing radiation.
Status:
Grant
Type:
Utility
Filling date:
28 Feb 2014
Issue date:
27 Oct 2020